Abbott Laboratories Com Stk NPV (NYSE:ABT)
Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Teacherman333
(26.16)
Submitted: 5/18/2013 4:32:52 PM :
Start Price:
$36.05
ABT Score:
+3.44
For reference point and to allow for comments by others. As of the end of March, 2013.
ROE 25.53%
Trailing PE 11.15
PB 2.54
Div yield 1.50%
Recs
0500305474
(46.52)
Submitted: 5/5/2013 9:34:22 PM :
Start Price:
$36.75
ABT Score:
+0.39
Spin off will let them focus on fast growing product
Recs
Recs
dreamjob
(81.71)
Submitted: 2/20/2013 6:05:10 AM :
Start Price:
$34.57
ABT Score:
+1.28
My Abbot Haiku:
Sales and earnings grow
Free cash flow in abundance
Big player priced right
Recs
sirhc1978
(69.55)
Submitted: 2/7/2013 10:37:56 AM :
Start Price:
$34.02
ABT Score:
+0.95
BIG INSIDE BUY
Recs
JorgeAura
(20.43)
Submitted: 2/2/2013 5:45:05 PM :
Start Price:
$33.24
ABT Score:
-3.60
sp500 in maximums.
Recs
stockdoc00
(< 20)
Submitted: 1/24/2013 12:39:36 PM :
Start Price:
$32.76
ABT Score:
+4.67
Very cheap at current prices. Essentially JNJ at a massive discount.
Recs
SpartanMAC
(38.51)
Submitted: 1/17/2013 7:39:39 PM :
Start Price:
$32.68
ABT Score:
+3.82
CAPS Greenblatt screen - 5 star stocks weighted with PE/PB, GM/ROE.
Recs
czheng393
(< 20)
Submitted: 1/13/2013 3:12:06 PM :
Start Price:
$33.07
ABT Score:
+4.30
Facing a spin off of AbbVie Laboratories which consists of the segment with the giant patent expiring in 2015. The rest of the ABT business will consist of supplements and such. Even though there is a competitive market out there, ABT has a good standing. The value of ABT is expected to go up after the spin off because AbbVie is a shareholder worry.
Recs
dlunas
(73.58)
Submitted: 1/10/2013 3:42:02 PM :
Start Price:
$33.56
ABT Score:
+0.07
Current Price $33.84
P/E Ratio 8.21
Div. (Yield) $0.56 (1.7%)
52-Wk Range $31.64 - $72.47
Recs
Arthur71
(86.01)
Submitted: 1/8/2013 9:08:30 PM :
Start Price:
$31.46
ABT Score:
-0.38
waiting....waiting....waiting....for FOOL to adjust for ABBV spin off.
Recs
just1man4picking
(< 20)
Submitted: 1/5/2013 5:45:46 PM :
Start Price:
$32.85
ABT Score:
+1.55
abt now has the most profitable part of old abt's business.
Recs
LocalLegend
(95.13)
Submitted: 1/5/2013 5:45:19 PM :
Start Price:
$31.04
ABT Score:
+4.40
Spin Off ABBV on the 1/2/13. Score should be corrected to account for Spin Off.
Recs
TerryHoodSr
(< 20)
Submitted: 1/4/2013 8:27:17 PM :
Start Price:
$32.90
ABT Score:
+1.44
hold after split
Recs
InvestorDeb
(71.47)
Submitted: 1/3/2013 3:20:27 PM :
Start Price:
$33.04
ABT Score:
+0.69
Abbott Labs is in the enviable position to be able to grow at levels far above its peers because of its strong positioning in the emerging markets, where it commands two times the exposure of its peers (40% of its total revenue, vs. 10%-20% for the group), led by markets in China and India. Of all its product lines, consumer nutritionals will be the largest segment at the company, and its above-average growth -- an expected 35% compound annual growth rate over the next three years -- will be heavily influenced by the demographic changes in China, which continue to improve.
They have plenty of cash to either increase the dividend or buy back shares (which management has shown a preference for). JPM conference next week could prove a short term catalyst, as well, though I am looking at it for the next 2-4 years.
Recs
bearbrewer
(77.79)
Submitted: 9/6/2012 9:56:20 PM :
Start Price:
$31.79
ABT Score:
+3.96
Cuz I say so.
Recs
as10675
(97.74)
Submitted: 8/5/2012 1:05:35 PM :
Start Price:
$21.49
ABT Score:
+37.98
8/5/12 Comments: Yield 3.06%. YOC 4.22%. 40 year Dividend Champion. Member Magnificent 7 stocks. Currently undervalued. Reinvesting dividends. Positions held in Brokerage, Traditional IRA and Roth IRA accounts.
Recs
Lulupoopsalot
(92.55)
Submitted: 7/9/2012 8:13:56 PM :
Start Price:
$29.21
ABT Score:
+3.25
Own in real life and love the company. Long term hold. Always buying on dips.
Recs
poder7
(< 20)
Submitted: 6/22/2012 10:21:29 AM :
Start Price:
$29.41
ABT Score:
-4.02
He is spending much money for divicion core business.
Recs
olbar
(< 20)
Submitted: 5/25/2012 11:45:32 AM :
Start Price:
$28.52
ABT Score:
+12.50
The Providence Health Care just Introduced ABBOTT Architect HIV Combo test to its Virology Labs.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 321 : 1 2 3 4 5 6 7 8 9 10 Next »